# OnCo record paper-keynote-024-nejm-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-keynote-024-nejm-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-keynote-024-nejm-2016" ;
  schema:name "KEYNOTE-024: pembrolizumab alone beats chemotherapy in PD-L1-high lung cancer"@en ;
  schema:description "In patients whose lung tumours carried PD-L1 on at least half their cells, pembrolizumab alone held the cancer back longer than chemotherapy and caused fewer serious side effects, making immunotherapy the first treatment for this group."@en ;
  schema:url <https://onco.cc/key-papers/paper-keynote-024-nejm-2016/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1606774>, <https://clinicaltrials.gov/study/NCT02142738> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1606774> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Reck M, Rodríguez-Abreu D, Robinson AG, et al." ;
  onco:related <https://onco.cc/roadmaps/lung-cancer-evidence-roadmap/>, <https://onco.cc/key-papers/paper-herbst-impower110-atezolizumab-pd-l1-nejm-2020/>, <https://onco.cc/biomarkers/pd-l1-tps/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/lung-cancer/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/merck/> ;
  onco:pathways <https://onco.cc/pathways/pd1-checkpoint/> ;
  onco:terms <https://onco.cc/terms/tps/>, <https://onco.cc/terms/pfs/>, <https://onco.cc/terms/os/>, <https://onco.cc/terms/ihc/> ;
  onco:trials <https://onco.cc/trials/keynote-024-189/> ;
  onco:people <https://onco.cc/people/martin-reck/> .